Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
1
Supervisor:
dr. Wim T. Kok
Student:
Panagiotis Spyropoulos (10457658)
Recent developments in affinity chromatography Literature Thesis
University of Amsterdam, The Netherlands
2
Table of Contents
1. Introduction ............................................................................................................. 4
1.1 General formats of affinity chromatographic applications ...................................... 5
2. Types and recent developments of affinity chromatography ................................... 7
2.1 Lectin Affinity Chromatography ............................................................................. 7
2.2 Boronate Affinity Chromatography......................................................................... 9
2.3 Immunoaffinity Chromatography .......................................................................... 11
2.4 Immobilized Metal-Ion Affinity Chromatography ................................................ 13
2.5 Protein A, G and L Affinity Chromatography ....................................................... 14
2.6 Analytical Affinity Chromatography..................................................................... 16
2.7 Dye-Ligand Affinity Chromatography .................................................................. 19
2.8 Aptamers ................................................................................................................ 23
2.9 Molecularly Imprinted Polymers ........................................................................... 25
2.10 Bioaffinity Chromatography ................................................................................. 27
2.11 Affinity Capillary Electrophoresis ........................................................................ 29
3. Conclusion ............................................................................................................. 32
References ..................................................................................................................... 33
3
MSc Chemistry
Analytical Sciences
Literature Thesis
Recent Developments in Affinity Chromatography
by
Panagiotis Spyropoulos
April, 2014
Supervisor:
dr. Wim T. Kok
4
1. Introduction
Affinity chromatography is a liquid chromatographic technique in which a specific
binding agent is used for the purification and analysis of sample components [1]. This
occurs by making use of a biological interaction between a protein or a group of
proteins and a specific binding agent coupled to a chromatography matrix [1].
This agent, which is known as the “affinity ligand”, selectively interacts with the
desired analyte in the sample and then it is placed into a solid support within a column
[2]. When this immobilized ligand has been prepared, it can be used for separation or
quantification of the analyte [2].
The most important factor for a successful affinity chromatographic method is the
immobilized ligand. The vast majority of affinity ligands, which are normally used,
come from a biological source like for example antibodies, enzymes, transport
proteins and carbohydrate binding proteins. In addition, synthetic ligands can be used
and more specifically metal ion chelates, boronates and biomimetic dyes [3].
According to the type of the ligand we can characterize different types of affinity
chromatography, like for example lectin affinity chromatography, boronate affinity
chromatography, immunoaffinity chromatography, immobilized metal ion affinity
chromatography and then discuss the developments on each one of them [3].
The type of support is also important for the design and use of the column. When
affinity chromatography is used only for sample pre-treatment or target isolation, a
carbohydrate support is preferred, like for example agarose or cellulose. The main
reason for this choice is the relatively easy modification for ligand attachment and
also the low non-specific binding for a variety of biological compounds. On the other
hand, the low efficiency and not so good mechanical stability of many carbohydrate-
based materials enhance the tendency of them to have better results during off-line
methods and with columns where the pressure and the flow rate is relatively low [4].
According to the type of support, new types of affinity chromatography can be used.
More specifically, high performance affinity chromatography (HPAC), or high
performance liquid affinity chromatography (HPLAC) is another type of affinity
chromatography, where silica particles can be used as HPLC media apart from
traditional carbohydrate based supports [5]. Another approach is affinity monolith
chromatography, in which recently developed monolithic materials are used in order
to attach the affinity ligand [6]. The most important advantage of HPAC depends on
the higher rigidness the efficiency of the particles or the synthetic polymers. As a
result, they have the ability to withstand under higher pressure and flow rate and they
possess better properties related to mass transfer than carbohydrate base supports.
Also, they can be combined with other HPLC columns and analytical methods on-line
and they are more precise, faster and easily automated in comparison with traditional
carbohydrate supports [5].
5
According to Magdeldin and Moser [7] affinity chromatography was firstly
introduced fifty years ago and in recent years the vast majority of purification
techniques (over 60%) contain affinity chromatographic applications.
1.1 General formats of affinity chromatographic applications
The format that is used for both traditional and high pressure affinity chromatographic
applications, in order to separate biomolecules, is the one shown in the following
figure.
Figure 1: General format for affinity chromatography [3].
The first step includes the injection of the sample in the affinity column, under
conditions that permit the target or the analyte of interest to bind to the immobilized
ligand in a robust way. An aqueous buffer with pH and ionic strength, that simulates
the inherent conditions of the ligand and its target, is regularly used in this kind of
applications. During the use of the buffer, the elution of compounds in the sample,
which do not interact much or at all with the ligand, is taking place and as a result a
non retained peak is created [3].
Later, the dissociation of the target from the affinity ligand occurs by using an elution
buffer. A basic requirement of this step is the alteration of the sample composition in
the mobile phase in order to enable the elution of the target. This can be achieved
6
either by changing the pH conditions or by adding a competing agent which is
responsible for the displacement of the target from the column. The collection of the
released target during this elution procedure is also possible and this target can be
analyzed later in order to provide more information. The direct monitoring of the
elution target, by using an HPLC support in the affinity column, is also feasible by an
on-line method. Combinations of both on-line and off-line methods with detection
methods like for example absorbance, fluorescence or mass spectrometry are also
possible. The regeneration of the column before the next application can be made by
passing through the original application buffer, after the elution of the target [8].
The scheme in the figure above is known as the “on/off” or step elution mode of
affinity chromatography and it is responsible for the capture and the elution of the
target [9]. This has been used in a wide range of applications not only in order to
isolate compounds but also for the preparation procedure of the sample, especially in
applications concerning biomedical and pharmaceutical analyses. The main reasons
for this choice are the fact that this issue can be characterized as simple, flexible,
selective, and relatively easy to use [1]. Additionally the automation of the format is
easy when affinity columns, which are suitable for HPAC applications or as a part of
HPLC systems, are used. Ultimately, this issue can be also used in order to detect
analytes directly. In the step of elution mode, on-line absorbance or fluorescence
detectors are used for this reason. Apart from these, mass spectrometric applications
and post column reactors can also be used [10].
Weak affinity chromatography (WAC) or dynamic affinity chromatography is an
approach of affinity chromatography used in various applications in pharmaceutical
and biomedical fields of study, where isocratic elution is operated, assuming that
retained targets have weak or moderate affinity for the immobilized ligand. The
development of these systems enables a single mobile phase to be used not only as the
sample application but also as the elution buffer [9].
Chiral separations which support affinity columns that consist of immobilized
enzymes like for example trypsin, a-chymotrypsin and cellobiohydrolase I or serum
proteins such as human serum albumin (HSA), bovine serum albumin (BSA) and 1-
acid glycoprotein (AGP), are characteristic examples where isocratic elution is used
[11].
Weak affinity chromatographic applications can be also utilized for the investigation
of drug screening assays. More specifically, the fragment-based drug discovery/
design screening of amidines, or arginine mimetic ligands can be achieved by using a
combination of WAC with trypsin and thrombin columns and also techniques, such as
HPLC and mass spectrometry [12]. This type of screening can be used in order to
evaluate ligands or inhibitors of cholera toxin. Moreover, high-throughput screening
of drug–protein interactions have also been investigated by using combinations of
affinity microcolumns with HSA [3].
7
An alternative format used mainly in the biomedical analysis field, is affinity
extraction. This approach contains the removal or extraction of a specific analyte or
group of analytes from the sample with a column which consists of an immobilized
affinity ligand. Then, the elution of the retained targets occurs and they pass to a
second system for analysis. Immunoextraction is a type of this format that is utilized
usually for antibodies which are placed in columns [13]. Ligands, such as boronates
or lectins, can be also used in this type of extraction. In HPAC applications, the
combination of affinity extraction with some ligands, enables the removal of the
targets from the samples really fast, namely in less than a few seconds. This
advantage is extremely helpful for the measurement of the free fractions of drugs and
hormones in serum or drug/protein mixtures, when columns which consist of
immobilized antibodies or HSA as the affinity ligand, are used [14].
An alternative method with relative connection to affinity extraction is affinity
depletion. In particular, an affinity column is used for the removal of abundant
compounds from a highly complicated sample, before the sample components, which
have not been retained, have been analyzed with a second technique. Antibodies are
commonly used within this technique as affinity ligands [13]. As far as the proteomics
field is concerned, the removal of highly abundant proteins is a characteristic
application, like for example HSA and immunoglobulin G (IgG) from serum, before
the analysis of the lower abundance proteins that exist in a sample, by using antibody
columns [3].
2. Types and recent developments of affinity chromatography
Based on the fact that affinity chromatography is widely applied, in this section all the
different types of affinity chromatography, as well as their recent applications and
developments will be presented.
2.1 Lectin affinity chromatography
One type of affinity chromatography, showing a rapid development over the past
decades is lectin affinity chromatography. In this powerful technique the immobilized
lectin is used as stationary phase [3]. Lectins are proteins that bind carbohydrate
residues under specific classification [15]. To be more specific, lectins are divided
into five groups according to their specificity to the monosaccharide. Hence,
according to Sharon [16] they present the highest affinity for mannose,
galactose/Nacetylgalactosamine, N-acetylglucosamine, fucose, and N-
acetylneuraminic acid.
In lectin affinity chromatography the protein is binding to an immobilized lectin
through its sugar moeities (N-linked or O-linked) [7]. Immobilized lectins are
8
extremely important for the separation and isolation of glycoconjugates,
polysaccharides, soluble cell components, and cells which consist of specific
carbohydrate structures. Another use of the immobilized lectins is dedicated to the
removal of any glycoproteins which are contaminated from purified proteins [17].
To be more specific, first of all the glycosylation of the protein takes place and then it
is ready for binding to the affinity support. The next step involves washing away any
remaining contaminants that have not been bound until then. Finally, the purification
of the protein occurs before the elution step, in order to complete the procedure [7].
There are many types of lectin affinity chromatography that can be used in different
scientific fields for research purposes. A significant number of them commercially
exist in an immobilized form. Two characteristic examples of this mode are
Concanavaline A (Con A) Sepharose and Wheat Germ Agglutinin (WGA) which are
widely used to purify glycoproteins [7].
Moreover, a great number of lectins can be used for more than one sugar hence they
can react with a number of different glycoproteins. One such example is Con A,
which does not own specificity and it is also known for binding enough glycoproteins,
polysaccharides and lysosomal hydrolases. Detergents like 0.1% sodium dodecyl
sulfate (SDS), 0.1% sodium deoxycholate, and 0.1% cetyltrimethyl-ammonium
bromide (CTAB) reduce the binding efficiency of Con A [17].
Another lectin with similar characteristics to Con A is Lens culinaris. The
disadvantage of this lectin however, is that its binding is not really strong. One
exception is when sodium deoxycholate is present, since in that case the binding of
the lectin can be efficient and as a result, it can be used in order to purify solubilized
membrane glycoconjugates. In addition, Wheat Germ Agglutinin lectin interacts with
mucins which contain N-acetylglucosamine residues and when 1% sodium
deoxycholate is present the lectin binds efficiently [17].
Finally, a last type of lectin after the isolation from the seeds of Artocarpus
integrifolia, is Jacalin which has a characteristic affinity for D-galactose residues.
According to recent articles and reports it can be used not only for the separation of
IgA1 from IgA2 subclass antibodies, but also for the removal of any IgA that has been
contaminated from preparation procedures of IgG that has been purified [17].
Another important field of study, where lectin columns with additional supports have
been used, is biomedical analysis. Initially coated polystyrene-divinylbenzene support
has been used for the preparation of M-LAC columns. The next step is the
combination of an M-LAC column with an antibody column as part of an automated
HPLC platform [18]. Another alternative is the use of isoelectric focusing with a
digital proteome chip especially for the field of proteomics studies. Generally, the
technique of LC-MS has extremely useful results as it helps the detection of any
changes happened in a wide variety of protein fractions which obtained either from
individuals without health problems or from others with a specific disease [19].
9
One last approach of lectin affinity chromatography is serial lectin affinity
chromatography (S-LAC), where sets of lectin columns are used in order to isolate
and purify glycoproteins and glycoconjugates. In this type, small agarose columns
which contain Con A, WGA or SNA are used and for the extraction step a hydrophilic
interaction column is used that helps for the enrichment of glycoproteins and
glycopeptides before they have been analysed by matrix-assisted laser
desorption/ionization mass spectrometry (MALDI MS) and liquid
chromatography/tandem mass spectrometry (LC–MS/MS) [20].
2.2 Boronate affinity chromatography
Another type of affinity chromatography used successfully with clinical samples,
includes boronates as ligands, hence it is defined as boronate affinity chromatography
[2]. This technique is one of the oldest identified in clinical laboratories and it was
used for diabetes control through the quantitative determination of glycohemoglobin
[2].
Boronate affinity chromatography is mainly based on the interaction between the
hydroxyl group of boronate and the molecules which contain cis-diol groups, such as
carbohydrates, nucleotides, nucleosides, glycoproteins, etc. [21]. The general
interaction between boronic acids and cis-diol-containing compounds is shown in
Figure 2 [22].
Figure 2.The general interaction between boronic acids and cis-diol-containing compounds [22].
Boronates are useful in separation of glycoproteins (e.g., glycohemoglobin) from non-
glycoproteins (e.g., normal hemoglobin), based on the fact that sugars such as glucose
owns cis-diol groups [2].
10
Methods developing this type of affinity chromatography have used both agarose and
supports that can be employed in HPAC techniques, while in other methods other
types of glycoproteins, such as glycated albumin and some apolipoproteins, have been
employed [3]. Moreover, boronate chromatography has also been used for the
analysis and measurement of hemoglobin A1c (HbA1c) which is the basic component
of glycated hemoglobin found in human blood [3].
In addition to the above, other types of glycated proteins in a sample can be examined
using boronate columns and changing the monitoring of the absorbance from 410-415
nm to 280 nm [23]. Last but not least, another method being used is the combination
of boronic acid columns and an immunoassay when the proteins of interest are for
instance the glycated albumin in serum and urine [24] or the glycated apolipoprotein
B in serum [25].
As far as recent developments in boronate affinity chromatography are concerned,
these include the separation of nucleosides, nucleotides and the ribose nucleic acid
mainly because of the 2′, 3′-diol interacting group [21]. Another important application
is the separation of RNA from the mixture of DNA and RNA based on the interaction
with boronate. In this occasion, there is no interaction for DNA molecules due to the
absence of 2′-hydroxyl group and subsequently the esterification of boronate ligand is
not possible. In addition, particular purification of 3′-phosphorylated ribonucleotides
and aminoacylated tRNA from a wide variety of nucleic acids and other biomolecules
can also be achieved [21].
What is more, during the last years developments concerning monolithic matrices
have been providing extremely significant results in the field of chromatographic
separation of biomolecules [26]. Monolithic columns are continuously integrated
porous separation media, without any inter-particular voids. Under pressure
conditions, the open channel network gives the opportunity to the mobile phase to
flow through the pores without restrictions. As a result, convective mass transfer in
less time compared to packed porous bead columns can be achieved. This type of
monolithic columns can be used in order to separate cis-diol containing biomolecules
and more specifically nucleosides and flavin adenine dinucleotide [21].
Another recent development of boronate ligands is the immobilization on 2-D
surfaces for the demonstration of the way that yeast [27] and mammalian cells [28]
are captured. As far as yeast cells are concerned, sugar moieties that are present on the
surface enable the adsorption on boronate grafted siliceous support under pH
conditions of 7.5. Relatively stable monolayer-like structures have been formed on the
surface of the boronate -grafted supports. However, the quantitative detachment is
possible due to competition of the fructose molecules that are present [29].
As far as the mammalian cancer cells are concerned, one characteristic of them is the
adherence on copolymer brushes that contain boronate on glass surface and
capillaries. Quantitative detachment of the attached cells from the grafted plates could
11
take place with 0.1M fructose solution and as a result, new developments concerning
cell separation methods could be examined. Also, either microbial or animal cells
with a sugar moiety localized on the cell wall can be separated [28].
But because monolithic columns’ pore size is a barrier on the movement of
mammalian cells, recent studies have examined the use of monolithic “cryogel”
matrices in order to overcome such limitations. The synthesis procedure of these
matrices occurs in lower temperature than the freezing one of the monomer or the
polymer solution [30]. Cryogels can be characterized for both their open
interconnected porous structure with large pore size and their relatively high
mechanical elasticity [31]. These characteristic properties enable cryogel based
matrices to be used for a wide variety of cell types and biomolecules during affinity
chromatographic separations. Additionally, for matrices of bioreactors and for the
design of tissue engineering scaffolds, the preparation and study of cryogels either
from natural polymers or other biocompatible polymers is extremely significant. Inert
hydrophilic polymers, which can be used for the synthesis procedure of different
matrices, are suggested in order to avoid non-specific interaction [21].
All these reasons enhanced the development of macroporous, inert and open
channeled matrices based on cryogels and combined with a boronate affinity ligand,
which was incorporated via copolymerization and graft polymerization steps, of a
boronate containing polymer. The created grafted cryogels can be valuable, not only
in order to characterize and to separate yeast cells, but also to fractionate both
adherent and non-adherent cells. Finally, an alternative approach for the synthesis of
the cryogel affinity column that contains boronate ligand is the copolymerization
method. This approach is often used in order to separate selectively RNA from the
nucleic acid mixture [21].
2.3 Immunoaffinity chromatography
Immunoaffinity chromatography is a technique where affinity columns which contain
immobilized antibodies or antibody-related agents are used. Moreover, when this
technique is used as a part of an HPLC system, it can be named as “high-performance
immunoaffinity chromatography” (HPIAC) [2].
During immunoaffinity chromatography and HPIAC applications there is a number of
different elution formats that can be used. The step elution mode, shown in Figure 1,
is the most widely used. During this mode, the retained target is being eluted by
changing the pH conditions on the mobile phase. An alternative way is to add an
organic modifier or a chaotropic agent [32]. Most of the times this mode is used when
target compounds are being isolated by immunoaffinity columns before these targets
have been analyzed by another method. Additionally, these targets can be detected
directly if they exist in sufficient levels in the sample. This mode has been used for
the measurement and transferring of different analytes like for example
12
acetylcholinesterase, benzidine, HSA, IgG and insulin. In order to detect these
different analytes, methods like absorbance, fluorescence, and mass spectrometry can
be used. Some additional detection schemes include pulsed amperometry and
radiometric detection [33].
Flow-based immunoassay or “chromatographic immunoassay” is a potential format
that can be also used with immunoaffinity chromatography and HPIAC [33]. There
are two different categories on these methods, namely competitive and non-
competitive immunoassays. In the first one, there is competition between a target
analyte and a labeled analyte analog for particular positions, where they can bind to
an antibody column. The step which follows is the detection of either the retained or
non-retained fraction of the labeled analog, using methods like fluorescence,
absorbance, chemiluminescence, or electrochemical formats. The measurement of the
total amount of target which was present in the original sample is not direct, as it can
be seen from the provided signal [33].
More specifically, the simultaneous injection mode, the sequential injection mode,
and the displacement immunoassay are three different options of immunoaffinity
chromatography for the performance of a competitive binding immunoassay [3].
Analytically, for the simultaneous injection mode the labeled analog and the target are
used at the same time onto a column, which contains only few immobilized antibodies
for these agents. For the sequential injection, initially target application takes place
and later the injection of the labeled analog occurs. For the last one, the displacement
immunoassay, first of all an excess of the labeled analog is adsorbed onto a column
where immobilized antibody exists. Then the application of a sample of the target
takes place to the column and a quantity of the labeled analog is displaced. Each one
of the three modes is employed for different applications. Simultaneous injection
immunoassays have been employed for the analysis of adrenocorticotropic hormone,
caffeine, cortisol, digoxin, gentamicin, HSA, IgG, methotrexate, testosterone, and
theophylline. Sequential injection immunoassays have been implemented for the
measurement of α-amylase, digoxin, HSA, and IgG and finally displacement
immunoassays for the analysis of benzoylecgonine, cocaine, cortisol, phenytoin, and
thyroxine [3].
As far as non-competitive immunoassays are concerned, two similar modes exist, the
one-site immunometric assay and the two-site immunometric assay [34]. The
procedure for the first one involves incubation of the sample with a known excess of
labeled antibodies that bind to the target. Following this, there is the injection of the
mixture onto a column which contains an immobilized analyte analog. The specific
role of this analog is the binding to any antibody that has not been bound to the target
until then and the elution of the binding antibodies as a non-retained fraction. There
are two ways for the final determination of the total amount of target that was present
in the original sample; either by measuring the amount of retained antibodies or non-
retained ones. One-site immunometric assay can be used on its own or as a step of
13
post column detection schemes for analytes such as digoxin, α-fetoprotein,
granulocyte colony-stimulating factor, interleukin-10, and thyroxine [35].
On the other hand, the main characteristic of a two-site immunometric assay or
sandwich immunoassay is the use of two different antibodies, which have the ability
to bind simultaneously to the same target. The first antibody is immobilized to a
support and it is utilized for the extraction of the target. The second one owns a label
which is extremely useful for the detection step. The elution of the retained target and
the labeled antibodies occurs after washing the column from non-retained components
and excess labeled antibodies. These labeled antibodies generate signal which is used
for the direct measurement of the amount of target in the sample. Characteristic
measurements of analytes in this mode are human chorionic gonadotropin, HSA, IgG,
interleukin-5, parathyroid hormone, and thyroid-stimulating hormone [33].
Concerning current developments in immunoaffinity chromatography, the
combination of it with other techniques for the analysis of complex biological
samples, has offered powerful insights in recent years. Two representative examples
of the above method are immunoextraction [13] and immunodepletion [36]. To be
more specific, off-line immunoextraction has been combined with HPLC, gas
chromatography (GC) and other methods for the determination of analytes as α1-anti-
trypsin, BSA, chloramphenicol, cortisol, clenbuterol and phenytoin, etc. On the other
hand, on-line immunoextraction methods, which combine immunoaffinity columns
with GC, mass spectrometry, ion-exchange chromatography, and capillary
electrophoresis, have also been useful leading to determination of drugs, proteins and
other interesting biomedical compounds. However, most of these on-line methods
include immunoextraction and reversed-phase HPLC, which is highly popular in
biological separations. This is due to the fact that an immunoaffinity column can
relatively easily be coupled with a reversed-phase column [13].
2.4 Immobilized Metal Ion affinity chromatography
Immobilized metal ion affinity chromatography (IMAC) firstly introduced by Porath,
Carlsson, Olsson and Belfrage [37], is another type of affinity chromatography which
has been showing huge growth when used in biomedical analysis [3]. IMAC was first
designated as “metal chelate chromatography” [38] and later metal ion interaction
chromatography and ligand-exchange chromatography before gaining its current term
as immobilized metal ion affinity chromatography [39].
IMAC is based on the interactions between immobilized metal ions and specific target
groups from the protein surface, such as amino acids, peptides, proteins, and nucleic
acids [3]. Furthermore, it has been widely approved that concerning amino acids,
histidine, tryptophan and cysteine residues play the most crucial role in the binding of
proteins in IMAC, due to their strong interaction with metal-ions [40]. In IMAC a
matrix is used and the metal ions are immobilized within a column through the use of
14
chelating groups like iminodiacetic acid, nitrilotriacetic acid, carboxymethylated-
aspartic acid, and l-glutamic acid. Metal ions that are often chelated to these groups
include Ni2+, Zn2+, Cu2+ and Fe3+ [40].
IMAC was originally named as “metal chelate chromatography” because it was first
developed for the isolation and separation of metal and histidine containing proteins
[37]. In this case, the sample is passed through an IMAC column, and firstly the
targets that can bind to the immobilized metal ions are retained and later a competing
agent is added or the pH is changed in order for the targets to be eluted [3].
Despite the use of IMAC for the purification of proteins, recently there is a wide
variety of other areas where it is applied [41]. To begin with, Takeda, Matsuoka and
Gotoh [42] report the employment of IMAC for the detection of drugs such as
tetracyclines, quinolones, macrolides, β-lactams, and aminoglycosides. Moreover,
Felix et al. [43] investigate the use of IMAC for detection of biomarkers in the serum,
urine, and tissues in order for diseases to be diagnosed. In this last case, the use of
IMAC has been combined with mass spectrometry in surface-enhanced laser
desorption/ionization (SELDI) [3]. Finally, in their work Sun, Chiu and He [44]
examine IMAC prior to mass spectrometry analysis for the enrichment of
phosphoproteins.
Another recent interest of the researchers towards the immobilized metal ion affinity
chromatography includes the refinement of IMAC for protein purification. IMAC has
not been used a lot for large scale protein purification, therefore researchers are highly
interested in the investigation of the above and more specifically of unexpected
conditions, like for example what happens if there is a leakage of metal ions from
IMAC columns [3]. In that case, the metal ions may interfere with the purity of the
protein raising concern for the researchers [3]. Another issue of concern is the
removal of the histidine tag from the recombinant protein when IMAC is used to
isolate recombinant histidine-tagged proteins, and its possible co-elution with other
proteins from the specific sample [45]. As a result of the above, there is a deep ground
for improvements as far as IMAC applications are concerned. The development of
new chelating ligands for IMAC, as well as methods to control better the selectivity of
IMAC while proteins are isolated from samples, are two examples of new issues that
researchers should investigate towards IMAC applications [3].
2.5 Protein A, G and L affinity chromatography
Proteins A, G and L are either native or recombinant proteins that originate from
microbes and their main characteristic is the specific binding to immunoglobulins,
including immunoglobulin G (IgG) that represents the 80% of serum
immunoglobulins [7]. Hence, protein A, G and L affinity column chromatography are
extremely helpful techniques, in order to isolate and purify IgGs from serum and other
biological fluids [46].
15
In particular, native and recombinant protein A is cloned in Staphylococcus aureus,
while recombinant proteins G and L are cloned in Streptococcus and
Peptostreptococcus magnus, respectively. The area of binding depends on the protein
that is used. Analytically, a specific binding in the Fc region of IgG is observed for
both proteins A and G, while the specific binding of protein L is taking place to the
kappa light chains of IgG [7].
According to many reports of affinity chromatographic applications where proteins A,
G and L are used, the category of matrix that is widely utilized is beaded agarose, like
for example Sepharose CL-4B or agarose cross linked with 2,3-dibromopropanol and
desulphated by alkaline hydrolysis under reductive conditions, polyacrylamide, and
magnetic beads [47,48].
Proteins A, G and L are characterized for their extensive binding with the IgG
subclass. This binding affinity varies in different immunoglobulin species. More
specifically, protein A declares stronger affinity binding for cat, dog, pig and rabbit
IgC and protein G for human or mouse IgG. In order to purify various IgG samples of
different mammals, the application of a recombinant protein of A and G is also
possible. As far as protein L is concerned, the specific binding of it to the kappa light
chain of immunoglobulins, which can be also found in other immunoglobulins like
IgG, IgM, IgA, and IgE, makes them appropriate in order to purify different classes of
antibodies. The binding of IgGs from the majority of species to proteins A and G
occurs under neutral pH and ionic strength conditions. A pH less than 2.7 is suggested
for the elution of immunoglobulins after their purification step [7].
Therefore, the main difference of these ligands is the binding to antibodies from
different species and classes. More specifically, the binding between protein G and
human IgG3 is stronger compared to the one with protein A. Moreover, there is a
weak interaction between protein A and human IgM, while there is no interaction
observed concerning protein G. Another protein that can be also used in this kind of
columns is A/G, a recombinant protein which is a mixture of both ligands’ activities
[2].
Protein A, G and L can be an extremely significant tool for scientists in the field of
analysis of immunoglobulins and mainly IgG-class antibodies, in humans. For this
reason, over the years numerous studies and reviews have been conducted around
protein A, G and L chromatographic techniques. For instance, Kitsiouli et al. [46]
examined protein G affinity chromatographical techniques and in particular the levels
of separation and purification of IgG from other proteins, while Hage [8] investigated
other applications of protein A and G, such as their use in order for antibodies to
adsorb onto supports that are going to be used in immunoaffinity chromatography.
This application is used mainly either for high antibody activities or when often
replacement of the antibodies in the column is wanted [2]. Concerning some of the
latest studies, Salvalaglio et al. [49] examined the design of mimetic ligands with
properties similar to those of protein A, while Holland et al. [50] investigated the
16
accuracy of the Protein G analysis of IgG for product specification and quality control
of colostrum products.
2.6 Analytical affinity chromatography
Analytical affinity chromatography, or else quantitative affinity chromatography or
biointeraction affinity chromatography is a method of affinity chromatography which
is used for studying interactions in biological systems [3]. A large number of articles
and reports, which have been written recently, examine this specific binding between
drugs and a wide range of agents including serum proteins, enzymes, and receptors
[1]. Moreover, specific interactions between biomolecules and lectins, aptamers and
antibodies have also been investigated. This type of affinity chromatography can
provide extremely significant and detailed information about the overall extent of
binding, the equilibrium constants for an interaction, the number and types of sites
involved in the binding process, and the rate constants for the interaction [51].
In many reports and studies, scientists in order to achieve these measurements, utilize
the zonal elution method. This method involves the injection of a small quantity of
sample of the drug or of the solute of interest into the mobile phase, where it can be
present either only the buffer or a competing agent with a standard concentration [2].
The determination of the changes on the elution time and the retention factor (k9 or
else capacity factor) of the solute that has been injected according to the concentration
values of the competing agent, is the best way for the analysis of the results. Closely
related studies have been conducted, for the investigation of the effect of interactions
between drugs and proteins to a wide range of solvent conditions, and also for the
development of quantitative structure-retention relationships that can be used in order
to further explore these binding processes [2].
The vast majority of reports and studies concerning HPLC affinity chromatographic
applications, and more specifically the zonal elution method, for binding between
drugs and hormones with proteins, are based on the investigation of the way that other
solutes displace drugs and hormones from proteins [2].
During these studies, injections of a target or probe are performed, while a competing
agent with a standard concentration in the mobile phase is present [1]. Exact
identification of the type of competition that takes place between these two solutes,
can occur by investigating the relationship between the change of the retention factor
of the target and the concentration of the competing agent. There are occasions where
data from previous works can be used for the determination of the association
equilibrium constants and also for the number of sites which are involved in the
interaction [52].
Characteristic examples include work that has examined the displacement of d,l-
thyronine and d,l-tryptophan from HSA by bilirubin or caprylate [53], the competition
17
of R/S-warfarin with racemic oxazepam, lorazepam, and their hemisuccinate
derivatives on an HSA column [54], the straight or allosteric competition of octanoic
acid on immobilized HSA for the binding sites of R/S-warfarin, phenylbutazone,
tolbutamide, R/S-oxazepam hemisuccinate, ketoprofen A/B, and suprofen A/B [55],
the competition either of R-warfarin and l-tryptophanV with d-tryptophan [56] or l-
thyroxine and related thyronine compounds on HSA [57], the displacement of R- and
S-ibuprofen by one another at their binding regions on HSA [58], and finally, the
effects of fatty acids on the binding of HSA with various drugs like for example
warfarin, phenylbutazone, tolbutamide, acetohexamide, and gliclazide [59].
Another possibility of the zonal elution method is the comparison of a wide variety of
coumarin and indole derivatives as potential probes for Sudlow sites I or II of HSA
[60]. During studies that have been conducted the last years, modifications on zonal
elution method have been made in order to investigate the allosteric interactions
which happen on HSA between ibuprofen and benzodiazepines, l-tryptophan and
phenytoin, or warfarin and tamoxifen [61]. Moreover, modifications have been made
on specific binding regions of HSA using either synthetic methods [62] or natural
processes, like for instance glycation [63]. Site-specific probes have also been used
for the investigation of changes that take place in solute interactions of a number of
competition studies [3].
Frontal analysis or frontal affinity chromatography is another method that can be used
especially for binding studies [64]. The main characteristic of this technique is the
continuous application of a target of known concentration to an affinity column,
where an immobilized binding agent is present. After taking place the saturation step,
the formation of a breakthrough curve occurs. The key point to the whole procedure is
either the mean position or the shape of the curve [63]. The determination of the exact
type of interaction that happens in the column depends on the mean position of the
curve, which can fit in a wide range of binding models. The parameters of the ideal
binding are also important and can provide valuable information on the equilibrium
constants and the number of binding sites that exist [1]. The shape of the
breakthrough curve, finally, is extremely helpful for studying interaction kinetics [65].
Some important applications of frontal analysis include the investigation of binding of
HSA to R/S-warfarin or d/l-tryptophan [3], the comparison of the binding between
monomeric and dimeric HSA for various drugs [66], the examination of the effects
based on chemical modification on the binding of site-specific probes with HSA [62]
and also the examination of multi-site binding of thyroxine with HSA [67]. In recent
studies, frontal analysis has been used for the examination of the total binding
between HSA and drugs like acetohexamide, carbamazepine, imipramine, lidocaine,
phenytoin, tolbutamide and verapamil [68]. Moreover, the interactions of a number of
coumarin and indole derivatives with HSA have been investigated [60]. Experiments
with the same method have been conducted for the investigation of interactions
between propranolol, carbamazepine, and lidocaine with AGP [69] and also
propranolol and verapamil with high-density lipoprotein [70].
18
Rapid developments and significant results have been also derived with the frontal
analysis method concerning the detection of multi-site binding [3]. The effect of
changing, either the mobile phase condition or the temperature on the affinity, and the
number of binding sites which are involved in a solute-ligand interaction have also
been examined. One example is the changes in binding by d/l-tryptophan to HSA
depending on pH [71]. The topic of many reports in the field of biological analysis is
the examination of the effect of temperature on biological interactions. More
specifically studies and experiments have been conducted about the interactions of
R/S-warfarin, d/l-tryptophan with HSA [72], propranolol and carbamazepine with
AGP [69] and also propranolol with high density lipoprotein [70]. This mode has been
extremely used for the determination of overall changes in drug or solute interactions
after modifying the binding regions of HSA [73].
Another approach of the frontal analysis method is its combination with mass
spectrometry, namely frontal affinity chromatography-mass spectrometry (FAC-MS)
[74]. This format can be characterized as an extremely significant tool, especially for
competitive binding experiments, due to its ability to distinguish mixtures of
compounds and their capability of binding to a given immobilized ligand [75].
Examples of binding agents that have been used with this technique are lectins,
enzymes and galactosaminoglycans [3].
As it has been also stated above, analytical affinity chromatography can provide
valuable information on the study of the kinetics of a biological interaction. Several
modes have been found for this type of research. First of all, the plate height method
is one example, where two different columns, one containing the affinity ligand of the
study and another one without ligand, are used [3]. The main function of this method
involves the measurement of the band broadening. The plot of the measured plate
heights of the analyte, versus the flow rate or the linear velocity, can help in order to
examine the contribution of the plate height based on stationary phase mass transfer,
which is connected to the dissociation rate between the target and the affinity ligand
[51]. Two characteristic experiments of this mode are the studies of the kinetics of
R/S-warfarin and d/l-tryptophan with HSA [76].
A variation on the plate height method is peak profiling, where measurements for
retention times and peak widths are conducted for both a target and a non-retained
solute on an affinity column [51]. As a first step, there is a comparison of these results
and then they are used for the determination of the rate constant, which is used for
target dissociation from the affinity ligand. The results for the non-retained solute are
used for the correction of band–broadening processes apart from the target with ligand
interaction [3]. One characteristic application of the method is the estimation of the
dissociation rate constants for l-tryptophan, carbamazepine, imipramine and
phenytoin metabolites from HSA [77]. Moreover, single or multiple flow rates have
been used in peak profiling methods and there have been tremendous developments in
the combination of this technique with solutes, which can interact with a number of
ways with the column, like for example binding to both the affinity ligand and the
19
support [3]. Finally, the combination of the method with chiral separations can assist
in the simultaneous examination of the interaction kinetics of HSA with the
enantiomers of drug metabolites [77].
A second approach of analytical affinity chromatography, which has been used for the
examination of the kinetics of biological interactions, is the peak decay method [3].
In this approach, firstly the injection of a pulse of a target onto a small affinity column
takes place. Then, in order to prevent the re-association of the target, which is
released from the affinity ligand, the mobile phase passes through really fast. The
decay curve which results under the appropriate conditions, helps the measurement of
the dissociation rate constant for the target from the ligand [51]. Recent applications
and reports refer to this method as it is used for the estimation of the dissociation rate
constants for a wide range of rugs from HSA [78]. It is also mentioned as an
important high- performance method, where affinity microcolumns and affinity
monoliths are used, in order to take the desired results or measurements [79].
Both zonal elution and frontal analysis methods have used curve fitting as a tool, in
order to extract valuable information on the kinetics of biological interactions [51].
More specifically, the profiles of frontal analysis methods have been used for the
examination of association kinetics for interactions between target and antibodies in
immunoaffinity columns [65]. These profiles have also been used for the examination
of interactions between targets and aptamers [3]. Apart from frontal analysis methods,
zonal elution experiments, which were conducted under non-linear elution conditions,
have also been used for the determination of the kinetics on studies with affinity
columns. One characteristic example of zonal elution experiment, which is referred to
many reports and articles, is the investigation of interactions between a wide range of
inhibitors with immobilized nicotinic acetylcholine receptor membrane columns [3].
2.7 Dye-ligand affinity chromatography
An alternative approach of affinity chromatography with extremely significant results
is dye-ligand affinity chromatography. In this type of affinity chromatography,
synthetic dyes compose the group of ligands than are employed in the technique [3].
The initial motivation for scientists to investigate more about dye ligand affinity
chromatography was given after the interactions that took place between Blue
Dextran, a Cibaron Blue and dextran conjugate, which is used as a void marker in
size-exclusion chromatography, and particular kinases. Until then, only purification of
various proteins by size-exclusion chromatography with Blue Dextran, like for
example, erythrocyte pyruvate kinase, phosphofructokinase, glutathione reductase,
and several coagulation factors had been initiated. The final conclusion of these
studies was that the main reason for protein binding was Cibacron Blue F3G-A, a
major reactive dye [80].
20
The first study, concerning the direct and covalent immobilization of Cibacron Blue
on Sephadex G-200 and also the purification of yeast pyruvate kinase with this
affinity sorbent, was conducted by Roschlau and Hess [81]. Later, there were many
articles and reviews dealing with this concept, which has been used in a wide variety
of applications in order to purify a wide range of proteins with a number of matrices
having this blue ligand.
In recent years, dye ligands have been widely used in affinity chromatography and
they have led to important results concerning protein purification [82]. The fact that
they are inexpensive, easily available, highly resistant to chemical or biological
degradation and readily immobilized constitutes some of their advantages [83].
The most popular dyes used for the purification of proteins are triazinyl-based
reactive dyes. The synthesis procedure is mainly based on Cyanuric chloride or
(1,3,5-trichloro-sym-triazine). In particular, the fact that electronegative atoms are
present is the reason for the three carbon atoms to be characterized as extremely
positive, and as a result they are very sensitive to nucleophilic attacks. The attachment
of chromophore molecules to this is extremely simple and so dichlorotriazinyl dyes
can be also formed [80].
A characteristic example of this category of dyes is the Procion MX series (from
Imperial Chemical Industries). These series can also react later with aniline,
sulfanilates or other nucleophilic substituents in order to produce monochlorotriazinyl
dyes like for example Cibacron (from Ciba-Geigy) or Procion H (from ICI). The
result of the coupling between two dichlorotriazinyl molecules and a bifunctional
molecule like diaminobenzene is the formation of bifunctional triazinyl dyes.
Characteristic examples are Procion H-E (from ICI), monofluoro-triazinyl (Cibacron,
Ciba-Geigy), trichloropyrimidnyl (Drimarene, Sandoz), and difluorochloropyrimidnyl
(Lavafix, Bayer and Drimarene, Sandoz) [80].
Apart from dyes based on triazinyl groups, one extremely significant series is the
Remazol series from Hoechst. This series is mainly based on the attachment to the
matrix due to the vinyl sulfone active groups that contain and because of this mode
they can be utilized as dye ligands in order to purify proteins [80].
Another type of ligand that can be also used in chromatographic applications is the
“biomimetic dye”. This ligand can be characterized as an extremely specific
unmodified dye. The main principle of this mode is the use of combinatorial
chemistry and computational methods for screening dyes and generally ligands for a
specific target. This mode can be a valuable tool for researchers in studies where it is
necessary to purify protein-based pharmaceuticals [3]. The production of these dyes
involves either personalization or redesign of the dye structure. This is the main
reason that textile dyes become more specific for target proteins. There are enough
studies and reports for this phenomenon from the beginning of 1980s, for example by
Lowe et al. [84], until recently with extremely important and successful results
21
especially for the recovery of a particular enzyme as suggested in the report of Clonis
et al. [85]. For the preparation of the first biomimetic dye, benzamidine was linked to
a chlorotriazine link which is really reactive with the help of a diaminomethylbenzene
group. This biomimetic dye was used in order to separate trypsin from chymotrypsin.
In the fields of bioinformatics and molecular modeling, extremely important
improvements concerning the synthesis of new series of biomimetic dye ligands, have
been noticed. In particular, anthraquinone-moiety-containing aromatic sulfonated
dyes, like Cibacron Blue 3GA, Procion Blue H-B and MX-R and Vilmafix Blue A-R
have a tendency to bind to the nucleotide-binding site and mimic the natural binding
of anionic coenzymes like NADH and FAD, in a wide range of proteins.
Anthraquinone dichlorotriazine dyes (such as VBAR) behave as affinity labels for
MDH (malate dehydrogenase) and LDH (lactate dehydrogenase). Improvement of the
way that l-lactate dehydrogenase is being purified can be made with the appropriate
biomimetic design of the ligand. In order to achieve this result, a three-dimensional
structural model of LDH is used as a guide and also some structural changes of the
dye molecules have occurred [80].
Biomimetic ligands, like for example mercaptopyruvic-, m-aminobenzoic-, and
amino-ethyloxamic-biomimetic dyes have been used for the purification of ketoacid-
group recognizing enzymes, such as formate dehydogenase, oxaloacetate
decarboxylase and oxalate oxidase. One last, recent application of molecular
modeling is the design of triazine non-dye ligands for Protein A, human IgG and
insulin precursor [80].
The main principle of the interactions between dye ligands and proteins is the specific
binding of dye molecules, which behave similarly to natural ligands, to the active
points of some protein molecules. A really important characteristic is the adsorption
of these proteins onto dye-ligand affinity sorbents. This fact enables the ligands to
easily interact with other parts of the proteins. The binding of the vast majority of the
proteins is not specific and involves extremely complicated combinations of different
kinds of bonds like for example electrostatic, hydrophobic or hydrogen. Moreover, all
of them have a great impact as far as the structure of the dyes is concerned [83].
As technology develops rapidly, dye-ligand affinity chromatography has been used in
many studies and it can be characterized as a significant tool for scientists and
researchers. Apart from the traditional mode, new types like affinity partitioning,
affinity precipitation and also expanded-bed chromatography have been developed
[1].
Affinity precipitation is mainly based on the particular affinity interactions of a
regular precipitation method. The main characteristics of this technique are the
selective precipitation of the complex created by the binding of a soluble ligand with
the target molecule, and as a result the increased degree of purification during the
elution of the target molecule. In order to achieve this, researchers have used
22
reversibly soluble polymers such as carboxymethyl cellulose and also
heterobifunctional ligands, where the conjugation of the affinity ligand is possible.
Changes in temperature, pH conditions and ionic strength are the main reason for the
precipitation of this complex. One characteristic example is the precipitation of lactate
dehydrogenase by using CB3GA conjugated to carboxyme thyl cellulose. The result
of this exceptional precipitation procedure is a 23-fold purification from an
unprocessed porcine extract [1].
Another mode of dye ligand affinity chromatography, that is also widely used, is
polymer-shielded dye-affinity chromatography (Figure 3). According to this, water-
soluble polymers can be used in order to improve the chromatographic process in a
significant degree. This technique is based on the creation of a complex between a
nonionic water-soluble polymer, such as poly(vinylpyrrolidone) or poly(vinyl
alcohol) and the dye matrix. These polymers are used in order to protect the dye from
non specific interactions with the target protein. The main advantage of this technique
is the really fast purification and this is the main reason that this technique has been
used for the purification of a large number of enzymes. One specific application of
this mode is to isolate lactate dehydrogenase from a crude porcine muscle extract as a
part of an expanded-bed system with the support Streamline-CB3GA. This
combination results in a 4.1-fold purification [1].
Figure 3: Polymer-shielded dye-affinity chromatography [1].
23
Dye ligand affinity chromatography has been used in various applications in order to
purify pharmaceutical proteins. Some characteristic applications are the purification
of human component factor B, fact or C2, factor II, factor IX, trypsin, chymotrypsin,
and proteinase 3. In detail, the purification of human recombinant alpha-interferon on
a mimetic dye-ligand matrix and also the purification of follicle-stimulating hormone,
pituitary gonadotropins, ricin A chain, and human serum albumin have been
investigated from scientists in different studies all these years. Albumin prepared by
CB3GA adsorbents have not been used in applications concerning the field of clinical
chemistry due to safety and toxicity regulations, but they are commonly used either
as a stabilizer for recombinant products or as an element of cell culture media [86].
Conventional affinity chromatographic applications with dye-ligands have been used
in order to remove small hydrophobic molecules and ions from biological fluids.
More specifically the coupling of CB3GA to poly(EGDMA-2-hydroxyethyl
methacrylate) (pHEMA) micro-beads was used for the removal of bilirubin from
human plasma in a packed-bed system. Additionally, this coupling can be also utilized
in order to remove A13+ and Fe3+ from human plasma. Another application of a dye
ligand column is the separation of G-DNA structures of which guanosine-rich
oligodeoxyribonucleotide is the main component. These separations are conducted on
a Reactive Green 19-agarose resin where Li+ ions are present [1].
Last but not least, the combination of an affinity extraction system with a reversed
micelle system has been used in order to extract lysozyme. The reversed micelle has
been generated by using a CB3GA-lecithin conjugate in n-hexane and enabled the
recovery of lysozyme in a high degree. As biospecific and steric-hindrance effects are
both present, this mode can be characterized as extremely selective and it is
appropriate in order to purify these low-molecular-weight proteins [1].
Finally, dye ligands have been used in order to remove toxic macromolecules such as
prion proteins, human immunodeficiency virus-1, or hepatitis B particles from
biological fluids. In particular, the azo dye Congo Red has been used due to the
specific binding of prion proteins and immobilized CB3GA has been utilized because
of the adsorption of envelope glycoproteins and also for the retention of the vast
majority of hepatitis B particles (more than 99.5%) from a human plasma sample [1].
2.8 Aptamers
Aptamers are synthetic nucleic acids which are characterized for their specific binding
to targets and as a consequence they are used in many affinity chromatographic
applications in order to recognize molecules [87].
The process which is used for the identification of aptamers to various chemical
targets is SELEX (systematic evolution of ligands by exponential enrichment). More
specifically, large amounts of nucleic acids with a functional role are being isolated in
24
a repetitive way through in vitro selection and then amplification follows through
polymerase chain reaction [88]. The category of targets contains both nucleic acid and
nonnucleic acid binding proteins, like for example growth factors and also enzymes,
antibodies and peptides. Another characteristic of aptamers is that they have been
related to the recognition of small molecules like for example amino acids,
nucleotides, drugs and dyes. This collection between target and aptamer was the
motive for in vivo and in vitro developments [89].
According to various reports aptamers were discovered in the beginning of 1990s. A
number of studies have provided information about their generation, which has
occurred all these years towards a broad range of targets such as peptides, amino
acids, small molecules and proteins, including cell membrane proteins. The affinity
exhibition of aptamers for their targets is high as it can be understood from the low
nanomolar to picomolar range of their Kd values [90].
Based on the study of Proske et al. [90], the discrimination between isoforms, with a
really close relationship or distinct structure states of the same target molecule, is
possible due to the exceptional specificity of the aptamers. Nonetheless, according to
Marro et al. [91] the selection of aptamers, which are responsible for the recognition
of murine and human protein targets with equal affinities, is also possible. This fact
enables their use in both preclinical and clinical developments.
Aptamers compared to antibodies, have the tendency of binding to functional domains
of the target protein such as substrate binding pockets or allosteric sites, thus the
modulation of the biological function of the molecule can be achieved. This benefit is
the motive for many studies and research projects concerning aptamer affinity
chromatography during the last years [90]. According to Farokhzad et al. [92], the
binding and the inhibitory behavior on carrier material is retained even after the
immobilization step. The same happens during the delivery into animals as Nimjee et
al. [93] reported, and certainly during the expression into cells.
According to a number of different reports many applications of aptamers in the field
of biotechnology provide extremely successful results. More specifically, Romig et al.
[89] examined the purification processes, Burgstaller et al. [94] the validation of the
target, Green et al. [95] the drug discovery area and finally, Nimjee et al. [93] the
diagnostics and therapy fields, respectively.
Consequently, and as technology develops rapidly, it is shown that aptamers can be
used in numerous applications. This significant progress in the field of aptamer
technology has provided extremely useful results to scientists, concerning different
fields of research, such as purification processes, target validation, diagnostics, drug
discovery, and therapeutic approaches [90].
As Zhao et al. [87] report, various analytical techniques such as electrochemistry,
quartz crystal microbalance, fluorescence, mass spectrometry, capillary
25
electrophoresis (CE) and polymerase chain reaction enabled the demonstration of
chromatographic assays which are based on the use of affinity aptamers.
In affinity chromatographic applications, aptamers can be used on stationary phase in
order to separate and quantify targets [96]. The benefits of this use are obvious when
antibodies are utilized as affinity ligands and more specifically the modification and
immobilization steps become easier and also the applications are more stable. In
addition, applications of aptamers to toxic compounds provide improved results and
the selection conditions are more flexible [97]. Moreover, batches of synthetic
aptamers are much more reproducible [96]. The vast majority of chromatographic
applications, which are based on aptamers, are connected to small molecules [87].
Apart from this, aptamers in affinity chromatographic applications can be used in
order to separate and detect proteins. The immobilization step of aptamers can take
place in open tubular capillaries, polymer monolithic columns and also microchannels
or columns that are packed with microbeads [87]. Finally, a number of novel
approaches for elution and immobilization steps, relied on the principles of
oligonucleotide chemistry, are also possible [97].
The main problem of using aptamers with low affinity is that during CE separation the
dissociation of the aptamer-target complex is possible. Solution to this problem has
been given by using aptamers with both weak and strong binding affinity in order to
avoid the restriction of affinity CE. One important advantage of using aptamers in
affinity chromatographic applications, mainly for the analytes which are present in
complex sample matrix, is the capture of the target analytes of interest in a selective
and efficient way [87].
One particular requirement in order to improve the sensitivity of the applications by
taking advantage of the preconcentration of targets is that targets with a strong
binding to the aptamer affinity column have to be eluted in a suitable way. What it is
also wanted is the capture and the elution of targets from the column stationary phase
without any damage of the latter. As a result, the affinity column can be used again
for similar purposes [87].
2.9 Molecularly Imprinted Polymers
Molecularly Imprinted Polymers (MIPs) is another group consisted of ligands and
supports whose use in affinity methods experiences huge growth in recent years.
Molecular imprinting is a technique which enables the production of artificial binding
sites in macroporous polymer particles, on surfaces or in membranes. These sites
demonstrate selective rebinding of the imprint or template molecules that are used
during their manufacture process [98]. All these years molecularly imprinted
polymers have been used in numerous applications like chromatographic media,
artificial antibodies, sensors and catalysts [99].
26
Molecularly imprinted materials own intrinsic properties in comparison with
enzymes, antibodies and biological receptors. They can be characterized as robust,
cheap and there is the possibility to use them in occasions where no recognizing
biomolecule is achievable [98].
During the preparation procedure of an imprinted polymer, the initial role of a
template or an imprint molecule is the management of the configuration of functional
monomers. Then the polymerization step with a high degree of cross linking follows,
and these monomers are frozen into position. Subsequently the template is removed,
and as a result cavities with counterbalancing size, shape and placement of functional
groups are made. Reversibility is the only requirement for the interactions between
the template and these functional monomers, which can be either covalent or non-
covalent [100].
In the vast majority of applications cavities consist of organic polymers based on
acrylate, acrylamide or styrene, yet the constitution of the cavities in silica is under
investigation. The production of them as bulk polymers is possible with many
different uses into microscopic particles, such as micron-scale beads or other bead
materials, combinations between micron-scale beads and thin surface layers, and
finally, as membranes [101].
Imprinted polymers have been widely applied during the last years. More specifically,
novel-cross linkers and monomers have been used in order to improve the
performance of such polymers [102]. In addition, imprinted polymer particles have
been used as stationary phase components in a number of thin-layer chromatographic
separations [103]. Last but not least, they have been used in many affinity capillary
electrophoresis applications [104].
In recent years, molecularly imprinted polymers are used as affinity based separation
media for sample preparation, namely molecularly imprinted SPE (MISPE) media.
There is a variety of modes concerning the molecularly imprinted SPE method, such
as online, offline, microextraction in packed syringe and also on-column extraction,
which all can be used in a significant number of pharmaceytical, environmental,
bioanalytical and food analysis applications. The greatest advantage of MISPE media
compared to the conventional SPE media is that they are more selective [99].
During a MISPE protocol procedure the loading, washing and elution steps of the
solvents play a crucial role. More specifically, in online modes the choice of washing
and eluting solvents is limited due to the RP LC separation that can take place. On the
other hand, in offline modes the selection of the solvents does not affect so much the
eluate, because later it will be separated and detected from an analyte in GC, LC, or
CE [105].
Additionally, molecularly imprinted polymers can be used either in compound
specific or in group specific extraction modes. In the first occasion, particular
extraction of the target compound is taking place by the application of a prepared MIP
27
for a target compound or its structurally related compound. In the second one, the
extraction of a target compound and its compounds with similar structural
characteristics occurs, such as a drug and its metabolites in biological fluids, a
herbicide and its degradation products in environmental samples and finally, an active
compound in crude extracts of traditional folk medicines and herbs [106].
As technology develops rapidly, fully automated and minituarized MISPE systems are
expected to be used in even more applications in the future. When MISPE
applications with high efficiency are needed, compound-specific and group-specific
MIPs are preferred to natural receptors and antibodies. Finally, another field of study,
which is expected to be investigated in future studies by researchers, is the preparation
of MIPs for a large molecule like for example a protein and a biologically important
compound [99].
2.10 Bioaffinity Chromatography
Bioaffinity chromatography is a type of affinity chromatography in which biological
compounds such as immunoglobulin-binding proteins, enzymes, lectins,
carbohydrates, avidin/biotin system and antibodies are used as ligands [1].
Immunoglobulin-binding proteins, namely protein A which is produced by
Staphylococcus aureus and protein G which is produced by streptococci, are the
ligands that are used in the vast majority of bioaffinity chromatographic applications
[107]. However, enzymes and enzyme inhibitors can also be used as affinity ligands
[1]. Immobilized enzymes are widely utilized in many applications, concerning
pharmaceutical and food industries. Furthermore, they are used in order to purify
enzyme inhibitors, as well as for the removal of impurities from unprocessed extracts.
In a similar way, enzyme inhibitors can be utilized for the purification of enzymes
from crude extracts [107]. The immobilization of enzymes on monolithic stationary
phases enables them to be used in a wide range of applications concerning bioaffinity
chromatography [108].
Nonetheless, as technology develops rapidly the demands for improvements and
advances in order to separate biomolecules in a more efficient way, as well as the
overwhelming of the restrictions, which specific stationary phases have, has
motivated researchers and scientists in order to search for materials that can replace
stationary phases used last decades [107].
Svec and Fréchet [109] developed continuous methacrylate rods from glycidyl
methacrylate (GMA) and ethylene dimethacrylate (EDMA) as monomer and
crosslinker. These two discoveries had a great impact, as they provided the platform
for non-particulate stationary phases and subsequently the generation of the name
‘‘monoliths’’.
28
Monoliths are continuous stationary phases which form as a homogeneous column in
a single piece and their preparation is taking place in various dimensions either with
agglomeration-type or with fibrous microstructures [110]. Therefore, affinity
monolith chromatography (AMC) is a liquid chromatographic technique, where a
monolithic support and a biologically related binding agent, as a stationary phase, are
used. This method can provide extremely useful results concerning the selective
separation, the analysis and the investigation of particular sample compounds [111].
There are two categories of monolithic materials, namely ‘‘organic’’ and
‘‘inorganic’’, according to the material that they are made from. The preparation of
organic monoliths is taking place when monomers, crosslinkers, porogens and an
initiator are polymerized in situ. Some characteristic examples of this category are
methacrylate and acrylamide (AAm) based polymers, poly(styrenedivinylbenzene),
agarose and cryogels. For the preparation of inorganic monoliths (silica), the sol-gel
method is applied or bare silica particles. The preparation schemes of monolithic
structure can have various formations like for example rods, CIM disks, capillaries
and microfluidic chips. The procedure involves initially the covalent immobilization
step and later in order to achieve the coupling of the ligand onto the stationary phase,
either biospecific adsorption or entrapment, are used [107].
Another classification, concerning monolithic materials is regarding their pores. There
are two caharacteristic types; macropores (the flow through pores) and
mesopores/micropores. As Tetala and van Beek [107] report, “the macropores have
diameters larger than 50 nm and enable the flow of mobile phase through the column
directing the sample to access the network of mesopores, which have pore diameters
in the range of 2–50 nm. Micropores have pores smaller than 2 nm”.
In the vast majority of affinity monolithic chromatographic applications the GMA-
EDMA copolymer system is used mainly because of its epoxide groups which are
available for ligand immobilization [112]. A typical GMA-EDMA monolith solution
consists of a monomer (GMA), crosslinker (EDMA), initiator and two porogenic
solvents [107]. One significant drawback of this system, however, is the low surface
area of GMA-EDMA monolith. In order to avoid this limitation relatively smaller
pore sizes should be used [113]. In their study, Kornyšova et al. [113] implement a
simple three-step method, where HEMA-PDA-DATD copolymers were used for the
formation of the monolithic bed. In this approach the attaching ligands can be
characterized more porous. The original monolith was composed of a monomer
(HEMA) and crosslinkers (PDA and DATD), an initiator and a catalyst.
A recent category of affinity monolithic stationary phases is the cryogels. The
exceptional characteristics of these phases are their hydrophilicity and their
macropores size in the range of 10–100 mm which is really large in comparison with
macropores of GMA-EDMA (1.5 mm) and silica monoliths (2 mm), respectively
[114]. A typical cryogel monolithic solution consists of AAm, allyl glycidyl ether and
29
N,N’-methylene bisacrylamide along with aqueous ammonium persulfate as initiator
and TEMED as accelerator [107].
An alternative approach of monolithic materials that is used in many applications is
the silica monoliths. These are present at two forms for ligand immobilization and
more specifically commercially available bare silica (e.g. Chromolith-Si) or
aminopropyl silica (e.g. Chromolith-NH2) and also sol–gel entrapment method [115].
Silica monoliths can be characterized as mechanically strong, with efficient results
and a high surface area. On the other hand, the restriction in the pH range (pH 2–8)
and also the decrease in the size represent the most important drawbacks of this type
of materials [116]. As far as the sol-gel method is concerned, the entrapment of the
ligand is taking place in a single step and the activity of the ligand remains without
any change. Nevertheless, the denaturation of the ligands, due to the alcoholic
byproducts which are released during the polymerization process, as well as the
decreased diameter of the column constitute important disadvantages of the method
[117].
Concluding, bioaffinity monolithic chromatography is expected to be used in a wide
range of applications in the future. This is due to the fact that this method has become
rough, not complicated and it can be performed in a conventional way without being
mandatory the investigation into depth for every application [107]. New forms are
going to be operated in order to recognize bacteria and also aptamers are going to be
used more often. Moreover, the investigation of new types of monoliths will also
include the study of present or alterative types of polymers, in order to come out with
a wider range of pore sizes, surface areas and new morphologies that can be used in
this type of affinity chromatography [111]. Finally, monolithic stationary phases are
expected to have a great impact on future applications, for instance if organic
monolithic supports will be combined with hybrids of silica [111].
2.11 Affinity Capillary Electrophoresis
One significant advantage of capillary electrophoresis (CE) is the separation of a
broad range of analytes at the same moment. Affinity Capillary Electrophoresis
(ACE) is a technique used in order to separate substances which participate either in
specific or in non-specific affinity interactions during the electrophoresis process, by
using a capillary electrophoresis format. The molecules can be free in solution or they
can be immobilized to a solid support [118].
There are three modes of affinity capillary electrophoresis, namely the non-
equilibrium electrophoresis of equilibrated sample mixtures, the dynamic equilibrium
affinity electrophoresis and the affinity-based capillary electrophoresis (CE) or
capillary electrochromatography (CEC) separations on immobilized selectors. In the
first one, the receptor and the ligand are in the sample and the electrophoresis
separation buffer is empty of both receptor and ligand. A portion of the total sample
30
solution is introduced into the capillary in order to begin the process. In the second
one, the receptor protein is in the sample and the ligand is placed in the
electrophoresis separation buffer. Inside the capillary binding and separation of the
affinity components is taking place. Finally, there are the affinity-based CE or CEC
separations on immobilized selectors. During this kind of separations the
immobilization of the receptor protein is taking place on the walls of a portion of the
capillary or microbeads, or membranes, or microchannels. The affinity related capture
of the ligand which exists either in a diluted solution or in a more complicated
mixture on the receptor is taking place. Later, components which are not connected
with the matrix are washed away and in addition the release of particular ligand from
adsorbed state occurs. The final step contains the performance of the separation by
capillary electrophoresis [118].
The use of ACE during recent years has provided significant results and advances in
biology and analytical chemistry. To be more specific, developments of CE in the
immunochemistry field are based on two different axes. The first one is the
miniaturization of immunoassays (lab-ona-chip) which enables rapid, relatively easy
and with high sensitivity measurements in the field of clinical chemistry. The second
one relies on CE applications in order to characterize in depth immunoreagents taking
into account the reactivity and the binding strength. One characteristic example is the
custom-made antibodies for particular affinity applications. One specific requirement
for the miniaturization process of immunoassays is the achievement of appropriate
detection limits which can be compared to the performance of traditional ELISAs. In
ELISA subpicomolar detection limits and parallel sample processing are necessary
[119].
There are also CE applications for analysis of proteins. Binding studies based on CE
are characterized from adsorption problems. A reproducible protein analysis demands
the appropriate working out conditions. One characteristic limitation of CE
applications is that the ideal conditions for protein separations, such as acidic PH, in
most of the cases are not the appropriate ones in order to study physiologically
relevant binding interactions. Low affinity interactions are used for the petides and
proteins analysis under the appropriate buffer conditions. The role of the new buffer
additives used is the connection with the analytes and by that means the shielding
from wall binding. One characteristic example is the use of mono and diquaternized
diamines in order to separate peptides and proteins [120].
Another approach of CE applications is the planning and characterization of
intramolecular interactions which are involved in protein folding. The determination
of various conformations contributed to long lifetimes, and also the wide range of
protein folding is the main reason for acceptable changes in the shape/size, charge
distribution, or exposure of interacting domains to change electrophoretic velocities
[121].
31
Furthermore, microelectrophoretic methods have been used for the investigation of
enzyme-substrate reactions which can be characterized as noncovalent molecular
interactions. Both the screening and the quantitative online characterization of
substrate formation and the inhibitor action can be conducted by electrophoretical
mixing. Moreover, the electrophoretically mediated microanalysis (EMMA) setup has
been used for the separation of zones of reactants and products [122].
In the field of biological reactions, carbohydrates are extremely crucial. Lectins, a
group of proteins with specific carbohydrate-binding capabilities, have been used in
many CE applications in order to identify and characterize parts of carbohydrates
[123]. On the other hand, the characterization of lectins is also possible by taking into
account the specific binding when panels of well-defined carbohydrates in CE are
used [124].
CE applications are evident for lipids, as well. The main problem however, is that
lipids in aqueous buffers can be characterized as insoluble and also they do not have
enough chromophores. Lipoconjugates such as lipoproteins and glycolipids, are
hydrophilic enough and as a result they are able for ordinary analysis techniques. In a
different way, the analysis of pure lipids can be conducted as micellar preparation, as
vesicles/liposomes, by creating mixed micelles when detergents are present and
finally by utilizing nonaqueous CE [125].
As far as the molecular biology field is concerned, CE applications have been used for
the investigation of DNA sequences. In addition there has been an increase in the
number of binding studies where DNA or RNA as analytes are involved. Two
subfields which have been developed in the last years contain the characterization of
small molecular ion–DNA interactions and drug–DNA/RNA interactions respectively
[126].
In addition, there are many studies and reports concerning the analysis of drug–
protein interactions. Drugs, protein–drug binding, enantiomers, and small molecules
CE-FA applications have been used in the vast majority of these studies. Moreover,
there are many studies based on HSA analyses because of the specific role that it has
about the administration of a wide range of drugs in humans. The determination of
protein binding and consequently the bioavailability of the drug candidates, that may
be used, have been examined with CE-FA methods [127].
Last but not least, CE applications have been used for the analysis of particles,
organelles, microorganisms, and eukaryotic cells, therefore also for their interactions,
based mainly on the inhomogeneous nature of the analytes [128].
32
3. Conclusion
As it has been shown throughout this review, in general affinity chromatography is an
alternative approach of traditional applications which take place in order to quantify
selective samples and examine a number of clinical samples. The greatest advantage
of this method is that for every compound in the field of clinical chemistry that has to
be analyzed, an independent affinity system can be created. There are many available
choices of ligands and operating formats used either for direct or indirect solute
determination.
Affinity chromatography provides valuable and important information about
separation methods in the fields of biomedical and pharmaceutical analysis. For this
reason, during the recent years, there has been reported significant growth on studies
focused on affinity chromatography. A number of different modes have been
examined until now, changing different parts of the whole mechanism, like for
example the type of support onto the column (traditional carbohydrate or HPLC
supports), the elution method (step or isocratic elution), and the affinity ligands
(lectins, boronates, antibodies, immobilized metal ions, dye ligands or aptamers).
Moreover, combinations with other analytical techniques such as reversed phase
HPLC, or mass spectrometry especially for the detection procedure can provide
satisfying results [3].
Additionally, affinity chromatography has been used in many new applications or
innovations which have helped many researchers to broaden their horizons of
knowledge and reconsider in a different way of view aspects of the technique. More
specifically, biological interactions and the competitive action between different
solutes for the binding sites are two characteristic examples. It is generally believed
that affinity chromatography will develop rapidly the following years and a large
number of new applications and modes are going to be investigated with this
technique. Researchers are almost sure that this technique will solve many problems
and will answer many questions manly during analysis of different biological and
pharmaceutical agents in really complex samples.
Finally, valuable information can be provided after using affinity chromatography in
clinical laboratories. A number of significant tests and applications can be conducted,
such as analysis of chiral drugs or examination of drug and hormone-protein binding.
The vast majority of these are specialized tests and it is almost sure that researchers
and scientists are going to use affinity chromatography even more in the future in
order to explore or investigate even more clinical samples or clinical applications.
Therefore, the future of affinity chromatography is undoubtedly promising not only
due to the impressive progress on bio-informatic tools, but also to the construction of
libraries which enable scientists and researchers to select robust, high-affinity ligands
[129]. The rapid development of high-throughput screening technologies also
enhances this option for the future.
33
References
[1] Hage, D. S. (Eds.). (2006). Handbook of affinity chromatography. 2nd ed., CRC Press.
[2] Hage, D. S. (1999). Affinity chromatography: a review of clinical applications. Clinical
chemistry, 45(5), 593-615.
[3] Hage, D. S., Anguizola, J. A., Bi, C., Li, R., Matsuda, R., Papastavros, E., Pfaunmiller, E., Vargas,
J., & Zheng, X. (2012). Pharmaceutical and biomedical applications of affinity chromatography: recent
trends and developments. Journal of pharmaceutical and biomedical analysis, 69, 93-105.
[4] Gustavsson, P. E., & Larsson, P. O. (2006). Support materials for affinity
chromatography. Handbook of affinity chromatography, 15-33.
[5] Yoo, M. J., & Hage, D. S. (2010). Affinity Monolith Chromatography: Principles and Recent
Developments. Monolithic Chromatography and Its Modern Applications, 1.
[6] Mallik, R., Xuan, H., & Hage, D. S. (2007). Development of an affinity silica monolith containing
α< sub> 1</sub>-acid glycoprotein for chiral separations.Journal of Chromatography A, 1149(2), 294-
304.
[7] Magdeldin, S., & Moser, A. (2012). Affinity Chromatography: Principles and Applications. Affinity
Chromatography, Rijeka: InTech.
[8] Hage, D. S. (1998). Survey of recent advances in analytical applications of immunoaffinity
chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 715(1), 3-28.
[9] Hage, D. S., Xuan, H., & Nelson, M. A. (2005). Application and elution in affinity
chromatography. Handbook of affinity chromatography, 2, 944.
[10] Kool, J., Giera, M., Irth, H., & Niessen, W. M. (2011). Advances in mass spectrometry-based
post-column bioaffinity profiling of mixtures. Analytical and bioanalytical chemistry, 399(8), 2655-
2668.
[11] Patel, S., Wainer, I. W., & Lough, W. J. (2006). Handbook of Affinity Chromatography. Hage,
DS., editor.
[12] Duong-Thi, M. D., Meiby, E., Bergström, M., Fex, T., Isaksson, R., & Ohlson, S. (2011). Weak
affinity chromatography as a new approach for fragment screening in drug discovery. Analytical
biochemistry, 414(1), 138-146.
[13] Moser, A. C., & Hage, D. S. (2010). Immunoaffinity chromatography: an introduction to
applications and recent developments. Bioanalysis, 2(4), 769-790.
[14] Mallik, R., Yoo, M. J., Briscoe, C. J., & Hage, D. S. (2010). Analysis of drug–protein binding by
ultrafast affinity chromatography using immobilized human serum albumin. Journal of
Chromatography A, 1217(17), 2796-2803.
[15] Kimura, K., Tanaka, I., Nishimura, S. I., Miyoshi, R., Miyoshi, T., & Watanabe, Y. (2012).
Further examination of polysaccharides causing membrane fouling in membrane bioreactors (MBRs):
Application of lectin affinity chromatography and MALDI-TOF/MS. Water research, 46(17), 5725-
5734.
[16] Sharon, N. (1998). Lectins: from obscurity into the limelight. Protein science,7(9), 2042-2048.
[17] West, I., & Goldring, O. (1996). Lectin affinity chromatography. In Protein Purification
Protocols (pp. 177-186). Humana Press.
[18] Kullolli, M., Hancock, W. S., & Hincapie, M. (2010). Automated platform for fractionation of
human plasma glycoproteome in clinical proteomics. Analytical chemistry, 82(1), 115-120.
[19] Zeng, Z., Hincapie, M., Pitteri, S. J., Hanash, S., Schalkwijk, J., Hogan, J. M., ... & Hancock, W.
S. (2011). A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC),
and isoelectric focusing to study the breast cancer proteome. Analytical chemistry, 83(12), 4845-4854.
[20] Calvano, C. D., Zambonin, C. G., & Jensen, O. N. (2008). Assessment of lectin and HILIC based
enrichment protocols for characterization of serum glycoproteins by mass spectrometry. Journal of
proteomics, 71(3), 304-317.
34
[21] Srivastava, A., Shakya, A. K., & Kumar, A. (2012). Boronate affinity chromatography of cells and
biomacromolecules using cryogel matrices. Enzyme and microbial technology, 51(6), 373-381.
[22] Li, H., & Liu, Z. (2012). Recent advances in monolithic column-based boronate-affinity
chromatography. TrAC Trends in Analytical Chemistry, 37, 148-161.
[23] Singhal, R. P., DeSilva, S. S. M., & Shyamali, M. (1992). Boronate affinity
chromatography. Advances in chromatography, 31, 293-335.
[24] Silver, A. C., Lamb, E., Cattell, W. R., & Dawnay, A. B. S. J. (1991). Investigation and validation
of the affinity chromatography method for measuring glycated albumin in serum and urine. Clinica
chimica acta, 202(1), 11-22.
[25] Panteghini, M., Bonora, R., & Pagani, F. (1994). Determination of glycated apolipoprotein B in
serum by a combination of affinity chromatography and immunonephelometry. Annals of Clinical
Biochemistry: An international journal of biochemistry in medicine, 31(6), 544-549.
[26] Guiochon, G. (2007). Monolithic columns in high-performance liquid chromatography. Journal of
Chromatography A, 1168(1), 101-168.
[27] Ivanov, A. E., Panahi, H. A., Kuzimenkova, M. V., Nilsson, L., Bergenståhl, B., Waqif, H. S., ...
& Mattiasson, B. (2006). Affinity Adhesion of Carbohydrate Particles and Yeast Cells to
Boronate‐Containing Polymer Brushes Grafted onto Siliceous Supports. Chemistry-A European
Journal, 12(27), 7204-7214.
[28] Ivanov, A. E., Eccles, J., Panahi, H. A., Kumar, A., Kuzimenkova, M. V., Nilsson, L., ... &
Mattiasson, B. (2009). Boronate‐containing polymer brushes: Characterization, interaction with
saccharides and mammalian cancer cells.Journal of Biomedical Materials Research Part A, 88(1), 213-
225.
[29] Ivanov, A. E., Galaev, I. Y., & Mattiasson, B. (2006). Interaction of sugars, polysaccharides and
cells with boronate‐containing copolymers: from solution to polymer brushes. Journal of molecular
recognition, 19(4), 322-331.
[30] Kumar, A., & Srivastava, A. (2010). Cell separation using cryogel-based affinity
chromatography. Nature protocols, 5(11), 1737-1747.
[31] Srivastava, A., Jain, E., & Kumar, A. (2007). The physical characterization of supermacroporous
poly (< i> N</i>-isopropylacrylamide) cryogel: Mechanical strength and swelling/de-swelling
kinetics. Materials Science and Engineering: A,464(1), 93-100.
[32] Hage D.S., Phillips T.M., Immunoaffinity chromatography, in: D.S. Hage (Ed.), Handbook of
Affinity Chromatography, 2nd ed., CRC Press, Boca Raton, FL, 2005, pp. 127–172.
[33] Moser, A.C. & Hage D.S., Chromatographic immunoassays, in: D.S. Hage (Ed.), Handbook of
Affinity Chromatography, 2nd ed., CRC Press, Boca Raton, FL, 2006 (Chapter 29).
[34] Hage, D. S., & Nelson, M. A. (2001). Peer Reviewed: Chromatographic
Immunoassays. Analytical chemistry, 73(7), 198-A.
[35] Oates, M. R., Clarke, W., Zimlich II, A., & Hage, D. S. (2002). Optimization and development of
a high-performance liquid chromatography-based one-site immunometric assay with
chemiluminescence detection. Analytica Chimica Acta,470(1), 37-50.
[36] Cellar, N. A., Karnoup, A. S., Albers, D. R., Langhorst, M. L., & Young, S. A. (2009).
Immunodepletion of high abundance proteins coupled on-line with reversed-phase liquid
chromatography: a two-dimensional LC sample enrichment and fractionation technique for mammalian
proteomics. Journal of Chromatography B, 877(1), 79-85.
[37] Porath, J., Carlsson, J. A. N., Olsson, I., & Belfrage, G. (1975). Metal chelate affinity
chromatography, a new approach to protein fractionation. Nature, 258, 598-599.
[38] Ueda, E. K. M., Gout, P. W., & Morganti, L. (2003). Current and prospective applications of metal
ion–protein binding. Journal of Chromatography A, 988(1), 1-23.
[39] Yip, T. T., & Hutchens, T. W. (1994). Immobilized metal ion affinity chromatography. Molecular
biotechnology, 1(2), 151-164.
35
[40] Gutierrez, R., Martín del Valle, E. M., & Galan, M. A. (2007). Immobilized metal‐ion affinity
chromatography: status and trends. Separation & Purification Reviews, 36(1), 71-111.
[41] Cheung, R. C. F., Wong, J. H., & Ng, T. B. (2012). Immobilized metal ion affinity
chromatography: a review on its applications. Applied microbiology and biotechnology, 96(6), 1411-
1420.
[42] Takeda, N., Matsuoka, T., & Gotoh, M. (2010). Potentiality of IMAC as sample pretreatment tool
in food analysis for veterinary drugs. Chromatographia, 72(1-2), 127-131.
[43] Felix, K., Fakelman, F., Hartmann, D., Giese, N. A., Gaida, M. M., Schnölzer, M., ... & Werner, J.
(2011). Identification of serum proteins involved in pancreatic cancer cachexia. Life sciences, 88(5),
218-225.
[44] Sun, X., Chiu, J. F., & He, Q. Y. (2005). Application of immobilized metal affinity
chromatography in proteomics.
[45] Pedersen, J., Lauritzen, C., Madsen, M. T., & Weis Dahl, S. (1999). Removal of N-terminal
polyhistidine tags from recombinant proteins using engineered aminopeptidases. Protein expression
and purification, 15(3), 389-400.
[46] Kitsiouli, E., Lekka, M. E., Nakos, G., Cassagne, C., & Maneta-Peyret, L. (2002). Lipids are co-
eluted with immunoglobulins G during purification by recombinant< i> streptococcal</i> protein G
affinity chromatography. Journal of immunological methods, 271(1), 107-111.
[47] Grodzki, A. C., & Berenstein, E. (2010). Antibody purification: affinity chromatography–Protein
A and Protein G Sepharose. In Immunocytochemical Methods and Protocols (pp. 33-41). Humana
Press.
[48] Katoh, S., Imada, M., Takeda, N., Katsuda, T., Miyahara, H., Inoue, M., & Nakamura, S. (2007).
Optimization of silica-based media for antibody purification by protein A affinity
chromatography. Journal of Chromatography A, 1161(1), 36-40.
[49] Salvalaglio, M., Zamolo, L., Busini, V., Moscatelli, D., & Cavallotti, C. (2009). Molecular
modeling of Protein A affinity chromatography. Journal of Chromatography A, 1216(50), 8678-8686.
[50] Holland, P. T., Cargill, A., Andrew, I., Selwood, Arnold, K., Jacqueline, L., Krammer, & Pearce,
K. N. (2011). Determination of Soluble Immunoglobulin G in Bovine Colostrum Products by Protein G
Affinity Chromatography-Turbidity Correction and Method Validation. Journal of Agricultural and
Food Chemistry, 59, 5248–5256.
[51] Schiel, J. E., & Hage, D. S. (2009). Kinetic studies of biological interactions by affinity
chromatography. Journal of separation science, 32(10), 1507-1522.
[52] Schiel, J. E., Joseph, K. S., & Hage, D. S. (2010). Biointeraction affinity chromatography: general
principles and recent developments. Adv. Chromatogr,48, 145-193.
[53] Dalgaard, L., Hansen, J. J., & Pedersen, J. L. (1989). Resolution and binding site determination of
D, L-thyronine by high-performance liquid chromatography using immobilized albumin as chiral
stationary phase. Determination of the optical purity of thyroxine in tablets. Journal of pharmaceutical
and biomedical analysis, 7(3), 361-368.
[54] Domenici, E., Bertucci, C., Salvadori, P., & Wainer, I. W. (1991). Use of a human serum
albumin‐based high‐performance liquid chromatography chiral stationary phase for the investigation of
protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding
sites. Journal of pharmaceutical sciences, 80(2), 164-166.
[55] Noctor, T. A., Wainer, I. W., & Hage, D. S. (1992). Allosteric and competitive displacement of
drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity
chromatography, on a human serum albumin-based stationary phase. Journal of Chromatography B:
Biomedical Sciences and Applications, 577(2), 305-315.
[56] Yang, J., & Hage, D. S. (1993). Characterization of the binding and chiral separation of D-and L-
tryptophan on a high-performance immobilized human serum albumin column. Journal of
Chromatography A, 645(2), 241-250.
[57] Loun, B., & Hage, D. S. (1995). Characterization of thyroxine-albumin binding using high-
performance affinity chromatography II. Comparison of the binding of thyroxine, triiodothyronines and
36
related compounds at the warfarin and indole sites of human serum albumin. Journal of
Chromatography B: Biomedical Sciences and Applications, 665(2), 303-314.
[58] Hage, D. S., Noctor, T. A., & Wainer, I. W. (1995). Characterization of the protein binding of
chiral drugs by high-performance affinity chromatography interactions of< i> R</i>-and< i> S</i>-
ibuprofen with human serum albumin. Journal of Chromatography A, 693(1), 23-32.
[59] Basiaga, S. B., & Hage, D. S. (2010). Chromatographic studies of changes in binding of
sulfonylurea drugs to human serum albumin due to glycation and fatty acids. Journal of
Chromatography B, 878(30), 3193-3197.
[60] Conrad, M. L., Moser, A. C., & Hage, D. S. (2009). Evaluation of indole‐based probes for
high‐throughput screening of drug binding to human serum albumin: Analysis by high‐performance
affinity chromatography. Journal of separation science, 32(8), 1145-1155.
[61] Chen, J., & Hage, D. S. (2006). Quantitative studies of allosteric effects by biointeraction
chromatography: analysis of protein binding for low-solubility drugs. Analytical chemistry, 78(8),
2672-2683.
[62] Chattopadhyay, A., Tian, T., Kortum, L., & Hage, D. S. (1998). Development of tryptophan-
modified human serum albumin columns for site-specific studies of drug–protein interactions by high-
performance affinity chromatography. Journal of Chromatography B: Biomedical Sciences and
Applications, 715(1), 183-190.
[63] Matsuda, R., Anguizola, J., Joseph, K. S., & Hage, D. S. (2011). High-performance affinity
chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with
glycated human serum albumin.Analytical and bioanalytical chemistry, 401(9), 2811-2819.
[64] Schriemer, D. C. (2004). Peer Reviewed: Biosensor Alternative: Frontal Affinity
Chromatography. Analytical chemistry, 76(23), 440-A.
[65] Nelson, M. A., Moser, A., & Hage, D. S. (2010). Biointeraction analysis by high-performance
affinity chromatography: kinetic studies of immobilized antibodies.Journal of Chromatography
B, 878(2), 165-171.
[66] Nakano, N. I., Shimamori, Y., & Yamaguchi, S. (1982). Binding capacities of human serum
albumin monomer and dimer by continuous frontal affinity chromatography. Journal of
Chromatography A, 237(2), 225-232.
[67] Tweed, S. A., Loun, B., & Hage, D. S. (1997). Effects of ligand heterogeneity in the
characterization of affinity columns by frontal analysis. Analytical chemistry,69(23), 4790-4798.
[68] Joseph, K. S., & Hage, D. S. (2010). Characterization of the binding of sulfonylurea drugs to HSA
by high-performance affinity chromatography. Journal of Chromatography B, 878(19), 1590-1598.
[69] Xuan, H., Joseph, K. S., Wa, C., & Hage, D. S. (2010). Biointeraction analysis of carbamazepine
binding to α1‐acid glycoprotein by high‐performance affinity chromatography. Journal of separation
science, 33(15), 2294-2301.
[70] Chen, S., Sobansky, M. R., & Hage, D. S. (2010). Analysis of drug interactions with high-density
lipoprotein by high-performance affinity chromatography.Analytical biochemistry, 397(1), 107-114.
[71] Yang, J., & Hage, D. S. (1996). Role of binding capacity versus binding strength in the separation
of chiral compounds on protein-based high-performance liquid chromatography columns Interactions
of d-and l-tryptophan with human serum albumin. Journal of Chromatography A, 725(2), 273-285.
[72] Loun, B., & Hage, D. S. (1992). Characterization of thyroxine—albumin binding using high-
performance affinity chromatography: I. Interactions at the warfarin and indole sites of
albumin. Journal of Chromatography B: Biomedical Sciences and Applications, 579(2), 225-235.
[73] Joseph, K. S., Anguizola, J., & Hage, D. S. (2011). Binding of tolbutamide to glycated human
serum albumin. Journal of pharmaceutical and biomedical analysis, 54(2), 426-432.
[74] Schiel, J. E., Ohnmacht, C. M., & Hage, D. S. (2009). Measurement of Drug− Protein Dissociation
Rates by High-Performance Affinity Chromatography and Peak Profiling. Analytical chemistry, 81(11),
4320-4333.
37
[75] Chan, N., Lewis, D., Kelly, M., Ng, E. S., & Schriemer, D. C. (2007). Frontal affinity
chromatography–mass spectrometry for ligand discovery and characterization. Mass Spectrometry in
Medicinal Chemistry: Applications in Drug Discovery, 217-246.
[76] Yang, J., & Hage, D. S. (1997). Effect of mobile phase composition on the binding kinetics of
chiral solutes on a protein-based high-performance liquid chromatography column: Interactions of d-
and l-tryptophan with immobilized human serum albumin. Journal of Chromatography A, 766(1), 15-
25.
[77] Tong, Z., & Hage, D. S. (2011). Characterization of interaction kinetics between chiral solutes and
human serum albumin by using high-performance affinity chromatography and peak profiling. Journal
of Chromatography A, 1218(39), 6892-6897.
[78] Chen, J., Schiel, J. E., & Hage, D. S. (2009). Noncompetitive peak decay analysis of drug–protein
dissociation by high‐performance affinity chromatography.Journal of separation science, 32(10),
1632-1641.
[79] Yoo, M. J., & Hage, D. S. (2011). Use of peak decay analysis and affinity microcolumns
containing silica monoliths for rapid determination of drug–protein dissociation rates. Journal of
Chromatography A, 1218(15), 2072-2078.
[80] Denizli, A., & Pişkin, E. (2001). Dye-ligand affinity systems. Journal of biochemical and
biophysical methods, 49(1), 391-416.
[81] Roschlau, P., & Hess, B. (1972). Affinity chromatography of yeast pyruvatekinase with Cibacron
blau bound to Sephadex G-200 Hoppe-Seyler’s. Z Physiol Chem, 353, 441–443.
[82] Labrou, N. E. (2003). Design and selection of ligands for affinity chromatography. Journal of
Chromatography B, 790(1), 67-78.
[83] Silva, M. S., Graça, V. C., Reis, L. V., Santos, P. F., Almeida, P., Queiroz, J. A., & Sousa, F.
(2013). Protein purification by aminosquarylium cyanine dye‐affinity chromatography. Biomedical
Chromatography, 27(12), 1671-1679.
[84] Lowe, C. R., Hans, M., Spibey, N., & Drabble, W. T. (1980). The purification of inosine 5′-
monophosphate dehydrogenase from< i> Escherichia coli</i> by affinity chromatography on
immobilized Procion dyes. Analytical biochemistry,104(1), 23-28.
[85] Clonis, Y. D., Labrou, N. E., Kotsira, V. P., Mazitsos, C., Melissis, S., & Gogolas, G. (2000).
Biomimetic dyes as affinity chromatography tools in enzyme purification. Journal of Chromatography
A, 891(1), 33-44.
[86] Burnouf, T., & Radosevich, M. (2001). Affinity chromatography in the industrial purification of
plasma proteins for therapeutic use. Journal of biochemical and biophysical methods, 49(1), 575-586.
[87] Zhao, Q., Li, X. F., Shao, Y., & Le, X. C. (2008). Aptamer-based affinity chromatographic assays
for thrombin. Analytical chemistry, 80(19), 7586-7593.
[88] Tombelli, S., Minunni, M., & Mascini, M. (2005). Analytical applications of aptamers. Biosensors
and Bioelectronics, 20(12), 2424-2434.
[89] Romig, T. S., Bell, C., & Drolet, D. W. (1999). Aptamer affinity chromatography:: combinatorial
chemistry applied to protein purification. Journal of Chromatography B: Biomedical Sciences and
Applications, 731(2), 275-284.
[90] Proske, D., Blank, M., Buhmann, R., & Resch, A. (2005). Aptamers—basic research, drug
development, and clinical applications. Applied microbiology and biotechnology, 69(4), 367-374.
[91] Marro, M. L., Daniels, D. A., McNamee, A., Andrew, D. P., Chapman, T. D., Jiang, M. S., ... &
Gearing, K. L. (2005). Identification of potent and selective RNA antagonists of the IFN-γ-inducible
CXCL10 chemokine. Biochemistry, 44(23), 8449-8460.
[92] Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T. N. T., LaVan, D. A., & Langer, R.
(2004). Nanoparticle-aptamer bioconjugates a new approach for targeting prostate cancer cells. Cancer
research, 64(21), 7668-7672.
[93] Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005). Aptamers: an emerging class of
therapeutics. Annu. Rev. Med., 56, 555-583.
38
[94] Burgstaller, P., Girod, A., & Blind, M. (2002). Aptamers as tools for target prioritization and lead
identification. Drug discovery today, 7(24), 1221-1228.
[95] Green, L. S., Bell, C., & Janjic, N. (2001). Aptamers as reagents for high-throughput
screening. Biotechniques, 30(5), 1094-100.
[96] Ravelet, C., Grosset, C., & Peyrin, E. (2006). Liquid chromatography, electrochromatography and
capillary electrophoresis applications of DNA and RNA aptamers. Journal of Chromatography
A, 1117(1), 1-10.
[97] Deng, Q., Watson, C. J., & Kennedy, R. T. (2003). Aptamer affinity chromatography for rapid
assay of adenosine in microdialysis samples collected in vivo. Journal of Chromatography A, 1005(1),
123-130.
[98] Ansell, R. J., Kriz, D., & Mosbach, K. (1996). Molecularly imprinted polymers for bioanalysis:
chromatography, binding assays and biomimetic sensors. Current opinion in biotechnology, 7(1), 89-
94.
[99] Haginaka, J. (2009). Molecularly imprinted polymers as affinity‐based separation media for
sample preparation. Journal of separation science, 32(10), 1548-1565.
[100] Wulff, G. (1993). The role of binding-site interactions in the molecular imprinting of
polymers. Trends in biotechnology, 11(3), 85-87.
[101] Kaiser, G. G., & Andersson, J. T. (1992). Sorbents for liquid chromatography based on the
footprint principle. Fresenius' journal of analytical chemistry,342(10), 834-838.
[102] Kempe, M., & Mosbach, K. (1995). Molecular imprinting used for chiral separations. Journal of
Chromatography A, 694(1), 3-13.
[103] Kriz, D., Kriz, C. B., Andersson, L. I., & Mosbach, K. H. (1994). Thin-layer chromatography
based on the molecular imprinting technique. Analytical Chemistry, 66(17), 2636-2639.
[104] Nilsson, K., Lindell, J., Norrlöw, O., & Sellergren, B. (1994). Imprinted polymers as antibody
mimetics and new affinity gels for selective separations in capillary electrophoresis. Journal of
Chromatography A, 680(1), 57-61.
[105] Martin, P. D., Jones, G. R., Stringer, F., & Wilson, I. D. (2003). Comparison of normal and
reversed-phase solid phase extraction methods for extraction of β-blockers from plasma using
molecularly imprinted polymers. Analyst, 128(4), 345-350.
[106] Claude, B., Morin, P., Bayoudh, S., & de Ceaurriz, J. (2008). Interest of molecularly imprinted
polymers in the fight against doping: extraction of tamoxifen and its main metabolite from urine
followed by high-performance liquid chromatography with UV detection. Journal of Chromatography
A, 1196, 81-88.
[107] Tetala, K. K., & van Beek, T. A. (2010). Bioaffinity chromatography on monolithic
supports. Journal of separation science, 33(3), 422-438.
[108] Petro, M., Svec, F., & Fréchet, J. M. (1996). Molded continuous poly (styrene-< i> co</i>-
divinylbenzene) rod as a separation medium for the very fast separation of polymers Comparison of the
chromatographic properties of the monolithic rod with columns packed with porous and non-porous
beads in high-performance liquid chromatography of polystyrenes. Journal of Chromatography
A, 752(1), 59-66.
[109] Svec, F., & Fréchet, J. M. (1992). Continuous rods of macroporous polymer as high-performance
liquid chromatography separation media. Analytical Chemistry,64(7), 820-822.
[110] Podgornik, A., & Štrancar, A. (2005). Convective Interaction Media®(CIM)–short layer
monolithic chromatographic stationary phases. Biotechnology annual review, 11, 281-333.
[111] Pfaunmiller, E. L., Paulemond, M. L., Dupper, C. M., & Hage, D. S. (2013). Affinity monolith
chromatography: a review of principles and recent analytical applications. Analytical and bioanalytical
chemistry, 405(7), 2133-2145.
[112] Vlakh, E. G., & Tennikova, T. B. (2007). Preparation of methacrylate monoliths.Journal of
separation science, 30(17), 2801-2813.
39
[113] Kornyšova, O., Jarmalavičienė, R., & Maruška, A. (2004). A simplified synthesis of polymeric
nonparticulate stationary phases with macrocyclic antibiotic as chiral selector for capillary
electrochromatography. Electrophoresis, 25(16), 2825-2829.
[114] Josic, D., Buchacher, A., & Jungbauer, A. (2001). Monoliths as stationary phases for separation
of proteins and polynucleotides and enzymatic conversion.Journal of Chromatography B: Biomedical
Sciences and Applications, 752(2), 191-205.
[115] Mallik, R., & Hage, D. S. (2008). Development of an affinity silica monolith containing human
serum albumin for chiral separations. Journal of pharmaceutical and biomedical analysis, 46(5), 820-
830.
[116] Tanaka, N., Kobayashi, H., Ishizuka, N., Minakuchi, H., Nakanishi, K., Hosoya, K., & Ikegami,
T. (2002). Monolithic silica columns for high-efficiency chromatographic separations. Journal of
Chromatography A, 965(1), 35-49.
[117] Kato, M., Sakai-Kato, K., Matsumoto, N., & Toyo'oka, T. (2002). A protein-encapsulation
technique by the sol-gel method for the preparation of monolithic columns for capillary
electrochromatography. Analytical chemistry, 74(8), 1915-1921.
[118] Heegaard, N. H., Nilsson, S., & Guzman, N. A. (1998). Affinity capillary electrophoresis:
important application areas and some recent developments.Journal of Chromatography B: Biomedical
Sciences and Applications, 715(1), 29-54.
[119] Wild, D. (Ed.), The Immunoassay Handbook, 2nd Edn., Nature Publishing Group, London 2001.
[120] Pontoglio, A., Viganò, A., Sebastiano, R., Citterio, A., Maragnoli, L., Righetti, P. G., & Gelfi, C.
(2004). Peptide and protein separations by capillary electrophoresis in the presence of mono‐and
diquaternarized diamines.Electrophoresis, 25(7‐8), 1065-1070.
[121] Heegaard, N. H., Jørgensen, T. J., Rozlosnik, N., Corlin, D. B., Pedersen, J. S., Tempesta, A. G.,
... & Nissen, M. H. (2005). Unfolding, aggregation, and seeded amyloid formation of lysine-58-cleaved
β2-microglobulin. Biochemistry, 44(11), 4397-4407.
[122] Burns, K. L., & May, S. W. (2003). Separation methods applicable to the evaluation of enzyme–
inhibitor and enzyme–substrate interactions. Journal of Chromatography B, 797(1), 175-190.
[123] Bergström, M., Nilsson, M., Isaksson, R., Rydén, I., Påhlsson, P., & Ohlson, S. (2004). Lectin
affinity capillary electrophoresis in glycoform analysis applying the partial filling technique. Journal of
Chromatography B, 809(2), 323-329.
[124] Nakajima, K., Kinoshita, M., Oda, Y., Masuko, T., Kaku, H., Shibuya, N., & Kakehi, K. (2004).
Screening method of carbohydrate-binding proteins in biological sources by capillary affinity
electrophoresis and its application to determination of Tulipa gesneriana agglutinin in tulip
bulbs. Glycobiology, 14(9), 793-804.
[125] Breyer, E. D., Howard, S., Raje, N., Allison, S., Apkarian, R., Brown, W. V., & Strasters, J. K.
(2003). Study of lipid and apolipoprotein binding interactions using vesicle affinity capillary
electrophoresis. Analytical chemistry, 75(19), 5160-5169.
[126] Rabiller-Baudry, M., & Chaufer, B. (2003). Small molecular ion adsorption on proteins and
DNAs revealed by separation techniques. Journal of Chromatography B, 797(1), 331-345.
[127] Schou, C., & Heegaard, N. H. (2006). Recent applications of affinity interactions in capillary
electrophoresis. Electrophoresis, 27(1), 44-59.
[128] Kremser, L., Blaas, D., & Kenndler, E. (2004). Capillary electrophoresis of biological particles:
viruses, bacteria, and eukaryotic cells. Electrophoresis,25(14), 2282-2291.
[129] Burgess, R. R., & Deutscher, M. P. (Eds.). (2009). Guide to protein purification(Vol. 463).
Academic Press.
40